| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 78492 |
|
2,171 |
2,142 |
$850K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
2,109 |
2,073 |
$318K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,524 |
1,492 |
$298K |
| 93015 |
|
4,202 |
4,054 |
$122K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
900 |
893 |
$87K |
| J2785 |
Injection, regadenoson, 0.1 mg |
849 |
834 |
$66K |
| 78431 |
|
365 |
355 |
$64K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,226 |
2,153 |
$42K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,113 |
1,061 |
$39K |
| 93925 |
|
224 |
224 |
$12K |
| 93880 |
|
304 |
304 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
277 |
277 |
$11K |
| 93923 |
|
184 |
181 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
719 |
692 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
316 |
298 |
$7K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
185 |
184 |
$6K |
| 93224 |
|
164 |
164 |
$6K |
| 78434 |
|
343 |
333 |
$3K |
| 93922 |
|
134 |
132 |
$3K |
| 93970 |
|
82 |
81 |
$3K |
| 93000 |
|
440 |
434 |
$2K |
| J1245 |
Injection, dipyridamole, per 10 mg |
2,092 |
2,039 |
$2K |
| 93978 |
|
13 |
13 |
$655.99 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
77 |
77 |
$430.22 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
206 |
200 |
$382.47 |
| 99080 |
|
125 |
25 |
$0.00 |